Tobi Podhaler (Inhalation)

Generic name:tobramycin (inhalation route) [ toe-bra-MYE-sin ]
Drug classes:Aminoglycosides, Inhaled anti-infectives

Medically reviewed by Drugs.com. Last updated on May 24, 2022.

Commonly used brand name(s)

In the U.S.

• Bethkis
• Kitabis Pak
• Tobi
• Tobi Podhaler

Available Dosage Forms:

• Solution
• Capsule

Therapeutic Class: Antibiotic

Chemical Class: Aminoglycoside

Uses for Tobi Podhaler

Tobramycin inhalation is used to treat lung infections in patients with cystic fibrosis. It is breathed into the lungs through the mouth to treat infections caused by the Pseudomonas aeruginosa bacteria.

Tobramycin belongs to a class of drugs called aminoglycoside antibiotics. It works by killing bacteria or preventing their growth. However, this medicine will not work for colds, flu, or other virus infections.

This medicine is available only with your doctor's prescription.

Before using Tobi Podhaler

In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:

Allergies

Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.

Pediatric

Appropriate studies have not been performed on the relationship of age to the effects of tobramycin inhalation in children younger than 6 years of age. Safety and efficacy have not been established.

Geriatric

Appropriate studies on the relationship of age to the effects of Bethkis® have not been performed in the geriatric population.

Although appropriate studies on the relationship of age to the effects of Tobi® or Tobi® Podhaler™ have not been performed in the geriatric population, no geriatric-specific problems have been documented to date. However, elderly patients are more likely to have age-related kidney problems, which may require caution and an adjustment in the dose for patients receiving this medicine.

Breastfeeding

There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.

Interactions with medicines

Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking this medicine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.

Using this medi...